Floatz logo

Naproxen

Sciatica

Ostfold Hospital TrustSmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

19 Active assets in the Sciatica cohort.

Asset / SponsorPhaseRating
LIDOCAINE
C.L.A.Vleggeert-Lankamp
Phase 4BBB
DEXAMETHASONE
University of Miami
Phase 4BBB
NEPENTHE
Akdeniz University
Phase 4BB
(RS)-KETOPROFEN
University Hospital, Grenoble
Phase 4BB
PREDNISONE TABLETS
Kaiser Permanente
Phase 3BB

View all 45 →

Same molecule, other indications

Naproxen is also rated in:

migraine disorderDormant
A
Indicative ·
80 / 100
View asset →
migraine disorderDormant
BBB
Indicative ·
72 / 100
View asset →
headache disorderDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →